Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 16.24 is 35% below its 5-year average of 24.94, near the low end of its 5-year range (16.24–44.96).
As of the fiscal period ended Tuesday, June 30, 2026. 28.84% below its 12-month average of 22.82.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.24.
CURRENT RATIO
16.24
CURRENT RATIO AVG TTM
22.82
CURRENT RATIO AVG 3Y
22.61
CURRENT RATIO AVG 5Y
24.94
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-28.84%
CURRENT VS 3Y AVG
-28.20%
CURRENT VS 5Y AVG
-34.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.73
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+335.86%
vs the sector median at left
Edgewise Therapeutics, Inc.
Market Cap
$4.28B
Current Ratio
16.24
TTM Avg
22.82
3Y Avg
22.61
5Y Avg
24.94
Market Cap
$4.41B
Current Ratio
4.79
TTM Avg
3.12
3Y Avg
4.00
5Y Avg
4.41
Market Cap
$4.41B
Current Ratio
0.84
TTM Avg
0.80
3Y Avg
0.95
5Y Avg
1.27
Market Cap
$4.43B
Current Ratio
5.08
TTM Avg
3.83
3Y Avg
4.06
5Y Avg
4.06
Market Cap
$4.05B
Current Ratio
12.77
TTM Avg
10.57
3Y Avg
9.28
5Y Avg
8.78
Market Cap
$4.00B
Current Ratio
18.27
TTM Avg
19.28
3Y Avg
20.00
5Y Avg
29.44
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.28B | 16.24 | 22.82 | 22.61 | 24.94 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.41B | 4.79 | 3.12 | 4.00 | 4.41 |
| LivaNova PLC (LIVN)vs › | $4.14B | 1.45 | 2.12 | 2.54 | 2.24 |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.41B | 0.84 | 0.80 | 0.95 | 1.27 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.43B | 5.08 | 3.83 | 4.06 | 4.06 |
| AbCellera Biologics Inc. (ABCL)vs › | $4.05B | 12.77 | 10.57 | 9.28 | 8.78 |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.00B | 18.27 | 19.28 | 20.00 | 29.44 |
| ICU Medical, Inc. (ICUI)vs › | $3.95B | 2.43 | 2.47 | 2.49 | 3.30 |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 1.47 | 1.61 | 1.69 | 1.64 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.67B | 6.95 | 6.77 | 6.23 | 10.87 |
Current Ratio
16.24
Quick Ratio
16.24
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 16.24 |
| 2026-03-31 | 22.61 |
| 2025-12-31 | 19.85 |
| 2025-09-30 | 26.51 |
| 2025-06-30 | 28.87 |
| 2025-03-31 | 20.99 |
| 2024-12-31 | 19.93 |
| 2024-09-30 | 26.35 |
| 2024-06-30 | 30.24 |
| 2024-03-31 | 37.08 |
| 2023-12-31 | 19.50 |
| 2023-09-30 | 18.23 |
| 2023-06-30 | 22.01 |
| 2023-03-31 | 26.22 |
| 2022-12-31 | 21.53 |
| 2022-09-30 | 27.82 |
| 2022-06-30 | 27.49 |
| 2022-03-31 | 26.85 |
| 2021-12-31 | 26.97 |
| 2021-09-30 | 33.50 |
| 2021-06-30 | 44.96 |
| 2021-03-31 | 64.02 |
| 2020-12-31 | 29.86 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
